Related Experiment Video
Updated: May 23, 2026
07:46
Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice
Published on: October 6, 2023
Stem cell therapy for retinal disease
Michael D Tibbetts1, Michael A Samuel, Tom S Chang
1Wills Eye Institute Retina Service, Mid Atlantic Retina, Philadelphia, Pennsylvania 19107, USA. michael.tibbetts@gmail.com
Current Opinion in Ophthalmology
|March 28, 2012
Summary
Stem cell therapy shows promise for retinal diseases, with ongoing trials exploring new cell sources and transplantation methods. Research is advancing, but challenges remain for widespread clinical application.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Retinal diseases pose significant challenges to vision and current treatments are limited.
- Stem cell therapy offers a promising avenue for regenerating damaged retinal tissues.
Purpose of the Study:
- To review advances in stem cell biology for retinal applications.
- To summarize current clinical trials for stem cell therapy in retinal diseases.
- To identify obstacles hindering the clinical viability of stem cell treatments for the retina.
Main Methods:
- Review of recent scientific literature on stem cell biology and retinal diseases.
- Analysis of data from ongoing and completed clinical trials.
- Identification of challenges in stem cell differentiation, transplantation, and efficacy.
Main Results:
- Stem cells can be directed to specific retinal cell fates with high purity.
- Induced pluripotent stem cells (iPSCs) offer a versatile source for retinal cell generation.
- Early clinical trials show preliminary safety and potential visual benefits for conditions like Stargardt's macular dystrophy and age-related macular degeneration.
Conclusions:
- Stem cell therapy is a rapidly advancing field for treating retinal diseases.
- Ongoing clinical trials are crucial for understanding the potential and limitations of these therapies.
- Further research is needed to overcome existing obstacles for successful clinical translation.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...